Clinical Trials in Los Angeles

Showing 661-680 of 16,901 trials

Retinoblastoma Patient Clinical Database and Tissue Repository

NCT04959097

Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed. Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.

RetinoblastomaRetinoblastoma BilateralRetinoblastoma Unilateral

Children's Hospital Los Angeles800 participantsStarted Jan 2017

Phoenix, Arizona, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +6 more locations

Active Not Recruiting< 1 mile

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

NCT06747572

The purpose of this study is to estimate the prevalence, demographic, and clinical characteristics of PKD1/2 gene variant groups in the ADPKD population.

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Vertex Pharmaceuticals Incorporated401 participantsStarted Dec 2024

Alabaster, Alabama, United States • Birmingham, Alabama, United States • Los Angeles, California, United States +42 more locations

Retinoblastoma Patient Clinical Database and Tissue Repository

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

Find Trials by Condition in Los Angeles

Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder

Comparison of Potassium Binders in the ER

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors